Position in RLAY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,935,709
+$2,343,606 QoQ
Shares Held
156,906
+163.7% QoQ
Ownership
0.072%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#93
of 256 holders
Holding Since
Sep 2020
18 quarters on record
Voting authority
Sole 0%
Shared 98%
None 2%
Common Shares in RLAY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLINGTON MANAGEMENT GROUP LLP holds $14,994,233,945 across 206 Biotechnology names. RLAY ranks #100 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,247,658 | $1,613,209,155 | |
| 2 | ARGX |
Argenx SE
|
930,548 | $863,334,513 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,270,087 | $791,950,042 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,843,415 | $719,794,757 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,110,407 | $635,295,816 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
7,651,415 | $606,680,693 | |
| 7 | CYTK |
Cytokinetics Inc
|
6,931,770 | $590,517,483 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
825,714 | $443,367,129 |
All Filings in RLAY
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,935,709 | 156,906 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $592,103 | 59,508 | Shares | Defined | 2026-05-15 | |
| 2024-06-30 | $468,871 | 71,913 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $443,334 | 53,414 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,113,782 | 101,161 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $749,347 | 89,102 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,101,926 | 87,733 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $14,007,733 | 850,500 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $15,708,288 | 1,051,425 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $14,728,071 | 658,385 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $34,293,145 | 2,047,352 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $60,473,982 | 2,020,514 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $61,375,406 | 1,998,548 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $44,389,225 | 1,407,841 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $46,402,961 | 1,268,187 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $29,215,243 | 845,104 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $5,965,147 | 143,531 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $9,403,358 | 220,788 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||